Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-480,000
Closed -$36.9M 28
2022
Q1
$36.9M Buy
480,000
+200,000
+71% +$14.4M 4.39% 9
2021
Q4
$21.4M Sell
280,000
-320,000
-53% -$23.5M 2.99% 18
2021
Q3
$44.3M Buy
+600,000
New +$45M 6.36% 5
2020
Q4
Sell
-357,833
Closed -$23.8M 31
2020
Q3
$23.8M Sell
357,833
-142,167
-28% -$9M 5.32% 6
2020
Q2
$28.5M Buy
+500,000
New +$24.5M 7.18% 2

Other funds holding HOLX

Iron Triangle Partners's HOLX Position: Q2 2022 in Review

Iron Triangle Partners sold out of Hologic (HOLX) in Q2 2022, closing a stake of 480,000 shares — an estimated $36.9M sold.

Iron Triangle Partners first reported a position in HOLX in Q2 2020 and held it in 5 quarters. The position peaked at $44.3M in Q3 2021. 694 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Iron Triangle Partners reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
  • Iron Triangle Partners sold 480,000 Hologic shares in Q2 2022, an estimated $36.9M.
  • Iron Triangle Partners first reported a position in Hologic in Q2 2020 and held it in 5 quarters.
  • Iron Triangle Partners's Hologic position peaked at $44.3M in Q3 2021.
  • 694 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Iron Triangle Partners's 13F filing for Q2 2022, filed 15 Aug 2022.